Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026)

Exelixis (EXEL) recorded quarterly Asset Utilization Ratio of 0.87 in Q2 2026, up 6.72% quarter-over-quarter from 0.82 in Q1 2026, and up 9.92% on a YoY basis from 0.79 in Q2 2025.

Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Exelixis' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.87 for Q2 2026.

  • In Q2 2026, Asset Utilization Ratio rose 9.92% year-over-year to 0.87; the TTM figure through Apr 2026 stood at 0.87 (up 9.92% YoY), while the FY2026 annual figure was 0.8, up 8.79% from the prior year.
  • Asset Utilization Ratio was 0.87 for Q2 2026 at Exelixis, up from 0.82 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.87 in Q2 2026 to a low of 0.51 in Q2 2022.
  • Historically, Asset Utilization Ratio has averaged 0.67 across 5 years, with a median of 0.64 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio decreased 0.39% in 2022, then jumped 32.42% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.53 in 2022, then rose by 15.78% to 0.62 in 2023, then grew by 17.42% to 0.73 in 2024, then rose by 14.56% to 0.83 in 2025, then rose by 5.03% to 0.87 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.87 (Q2 2026), 0.82 (Q1 2026), and 0.83 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 0.55
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 1,422.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.47
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 0.87

Historic Data

Download Data
DateValue
Apr 3, 2026 0.87
Jan 2, 2026 0.82
Oct 3, 2025 0.83
Jul 4, 2025 0.81
Apr 4, 2025 0.79
Jan 3, 2025 0.73
Sep 27, 2024 0.73
Jun 28, 2024 0.72
Mar 29, 2024 0.64
Dec 29, 2023 0.62
Sep 29, 2023 0.58
Jun 30, 2023 0.55
Mar 31, 2023 0.54
Dec 30, 2022 0.53
Sep 30, 2022 0.52
Jul 1, 2022 0.54
Apr 1, 2022 0.51
Oct 1, 2021 0.52
Jul 2, 2021 0.51
Apr 2, 2021 0.48